FM
Frazier Management Portfolio holdings
AUM
$1.12M
1-Year Return
150.24%
This Quarter Return
-4.68%
1 Year Return
+150.24%
3 Year Return
+430.4%
5 Year Return
+1,926.83%
10 Year Return
–
AUM
$1.08B
AUM Growth
-$162M
(-13%)
Cap. Flow
-$65.3M
Cap. Flow
% of AUM
-6.02%
Top 10 Holdings %
Top 10 Hldgs %
77.96%
Holding
37
New
2
Increased
1
Reduced
8
Closed
3
Top Buys
| 1 |
Iovance Biotherapeutics
IOVA
|
$21.5M |
| 2 |
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
|
$15.5M |
| 3 |
AUTL
Autolus Therapeutics
AUTL
|
$15.2M |
Top Sells
| 1 |
Arcutis Biotherapeutics
ARQT
|
$57.5M |
| 2 |
Tarsus Pharmaceuticals
TARS
|
$14.5M |
| 3 |
Adverum Biotechnologies
ADVM
|
$14.2M |
| 4 |
Krystal Biotech
KRYS
|
$7.28M |
| 5 |
Aclaris Therapeutics
ACRS
|
$5.71M |
Sector Composition
| 1 | Healthcare | 95.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Scholar Rock
SRRK
$3.1B
| $4.51M | 0.42% |
156,000
| – | – |
|
|
FRLN
27
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
| $4.48M | 0.41% |
36,667
| – | – |
|
|
ALNA
28
DELISTED
Allena Pharmaceuticals, Inc. Common Stock
ALNA
| $4.33M | 0.4% |
3,330,373
| – | – |
|
|
BLU
29
DELISTED
BELLUS Health Inc.
BLU
| $4.03M | 0.37% |
1,296,743
| – | – |
|
|
SRRA
30
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $3.95M | 0.36% |
202,803
| – | – |
|
|
AVDL
31
Avadel Pharmaceuticals
AVDL
$1.42B
| $3.89M | 0.36% |
578,104
| – | – |
|
32
Immunovant
IMVT
$2.87B
| $2.69M | 0.25% |
254,000
-254,000
| -50% | -$2.69M |
|
|
GRTX
33
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
| $2.37M | 0.22% |
241,000
| – | – |
|
|
NBRV
34
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| $575K | 0.05% |
17,026
| – | – |
|
|
35
Adverum Biotechnologies
ADVM
$67.4M
| – | – |
-143,703
| Closed | -$14.2M |
|
36
Cardiff Oncology
CRDF
$136M
| – | – |
-293,500
| Closed | -$2.72M |
|
37
Iterum Therapeutics
ITRM
$28.2M
| – | – |
-102,554
| Closed | -$2.17M |
|